Login to Your Account

Roche Pays Gilead $62.5M To Settle Tamiflu Dispute

By Randall Osborne

Thursday, November 17, 2005
To more quickly "address [the] global public health need" of a vaccine against the avian flu, Gilead Sciences Inc. and F. Hoffmann-La Roche Ltd. are ending their dispute over Tamiflu, and $62.5 million is changing hands. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription